585 results on '"Geerlings, P."'
Search Results
2. Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies.
- Author
-
Twait, Emma L., Kamarioti, Maria, Verberk, Inge M.W., Teunissen, Charlotte E., Nooyens, Astrid C.J., Monique Verschuren, W.M., Visser, Pieter Jelle, Huisman, Martijn, Kok, Almar A.L., Eline Slagboom, P., Beekman, Marian, Vojinovic, Dina, Lakenberg, Nico, Arfan Ikram, M., Schuurmans, Isabel K., Wolters, Frank J., Moonen, Justine E.F., Gerritsen, Lotte, van der Flier, Wiesje M., and Geerlings, Mirjam I.
- Abstract
• What is the primary question addressed by this study? The current study aimed to assess if late-life depressive symptoms were associated with plasma amyloid-beta42/40, p-tau181, neurofilament light, or glial fibrillary acidic protein. • What is the main finding of this study? Late-life depressive symptoms were not associated with plasma biomarkers for Alzheimer's disease pathology, axonal injury, or astrocytic activation. • What is the meaning of the finding? In those with a genetic risk for Alzheimer's disease, axonal injury was associated with increased depressive symptoms. Depressive symptoms are associated with an increased risk of Alzheimer's disease (AD). There has been a recent emergence in plasma biomarkers for AD pathophysiology, such as amyloid-beta (Aβ) and phosphorylated tau (p-tau), as well as for axonal damage (neurofilament light, NfL) and astrocytic activation (glial fibrillary acidic protein, GFAP). Hypothesizing that depressive symptoms may occur along the AD process, we investigated associations between plasma biomarkers of AD with depressive symptoms in individuals without dementia. A two-stage meta-analysis was performed on 2 clinic-based and 6 population-based cohorts (N = 7210) as part of the Netherlands Consortium of Dementia Cohorts. Plasma markers (Aβ42/40, p-tau181, NfL, and GFAP) were measured using Single Molecular Array (Simoa; Quanterix) assays. Depressive symptoms were measured with validated questionnaires. We estimated the cross-sectional association of each standardized plasma marker (determinants) with standardized depressive symptoms (outcome) using linear regressions, correcting for age, sex, education, and APOE ε4 allele presence, as well as subgrouping by sex and APOE ε4 allele. Effect estimates were entered into a random-effects meta-analysis. Mean age of participants was 71 years. The prevalence of clinically relevant depressive symptoms ranged from 1% to 22%. None of the plasma markers were associated with depressive symptoms in the meta-analyses. However, NfL was associated with depressive symptoms only in APOE ε4 carriers (β 0.11; 95% CI: 0.05–0.17). Late-life depressive symptoms did not show an association to plasma biomarkers of AD pathology. However, in APOE ε4 allele carriers, a more profound role of neurodegeneration was suggested with depressive symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Bond Lengths and Dipole Moments of Diatomic Molecules under Isotropic Pressure with the XP-PCM and GOSTSHYP Models
- Author
-
Eeckhoudt, Jochen, Alonso, Mercedes, Geerlings, Paul, and De Proft, Frank
- Abstract
While high-pressure chemistry has a well-established history, methods to simulate pressure at the single-molecule level have been somewhat lacking. The current work aims at comparing two static models (XP-PCM and GOSTSHYP) to apply isotropic pressure to single molecules, focusing on the equilibrium bond length and electric dipole moment of diatomic molecules. Numerical challenges arising in the potential energy surface using the XP-PCM method were examined, and a pragmatic approach was followed to mitigate these. The definition of the cavity was scrutinized, and two approaches to retrieve the isotropic character that could potentially be lost when using the standard methodology were suggested. Subsequently, equilibrium bond lengths under pressure were evaluated, showing reasonable agreement between GOSTSHYP and XP-PCM, but some discrepancies persist. A Taylor series analysis introduced elsewhere was then applied to rationalize the observed trends in terms of the bond surface. Finally, the dipole moment was shown to be highly sensitive to the cavity definition, and qualitative agreement necessitates the use of our adapted procedure.
- Published
- 2024
- Full Text
- View/download PDF
4. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
- Author
-
Oomen, Patrick G A, Wit, Ferdinand W N M, Brinkman, Kees, Vrouenraets, Saskia M E, Mudrikova, Tania, van Welzen, Berend J, van der Valk, Marc, van Agtmael, M.A., Bomers, M., Geerlings, S.E., Goorhuis, A., Harris, V.C., Hovius, J.W., Lemkes, B., Nellen, F.J.B., Peters, E.J.G., van der Poll, T., Prins, J.M., Sigaloff, K.C.E., Spoorenberg, V., van Vugt, M., Wiersinga, W.J., Bruins, C., van Eden, J., Hylkema-van den Bout, I.J., Laan, L.M., Pijnappel, F.J.J., Smalhout, S.Y., Spelbrink, M.E., Weijsenfeld, A.M., Back, N.K.T., Cornelissen, M.T.E., van Houdt, R., Jonges, M., Jurriaans, S., Schinkel, C.J., Welkers, M.R.A., Wolthers, K.C., van den Berge, M., Stegeman, A., Baas, S., Hage de Looff, L., van Arkel, A., Stohr, J., Wintermans, B., Pronk, M.J.H., Ammerlaan, H.S.M., de Bree, C., de Munnik, E.S., Phaf, S., Deiman, B., Jansz, A.R., Scharnhorst, V., Tjhie, J., Wegdam, M.C.A., Nellen, J., van Eeden, A., Hoornenborg, E., de Stoppelaar, S., Alers, W., Elsenburg, L.J.M., Nobel, H., Schinkel, C.J., van Kasteren, M.E.E., Berrevoets, M.A.H., Brouwer, A.E., de Kruijf-van de Wiel, B.A.F.M., Adams, A., Pawels-van Rijkevoorsel, M., Murck, J.L., Rokx, C., Anas, A.A., Bax, H.I., van Gorp, E.C.M., de Mendonça Melo, M., van Nood, E., Nouwen, J.L., Rijnders, B.J.A., Schurink, C.A.M., Slobbe, L., de Vries-Sluijs, T.E.M.S., Bassant, N., van Beek, J.E.A., Vriesde, M., van Zonneveld, L.M., de Groot, J., van Kampen, J.J.A., Koopmans, M.P.G., Rahamat-Langendoen, J.C., Branger, J., Douma, R.A., Cents-Bosma, A.S., Mulder, M.A., Schippers, E.F., van Nieuwkoop, C., Geilings, J., van de Ven, E., van der Hut, G., van Burgel, N.D., Leyten, E.M.S., Gelinck, L.B.S., Mollema, F., Langbein, M., Wildenbeest, G.S., Nguyen, T., Groeneveld, P.H.P., Bouwhuis, J.W., Lammers, A.J.J., van Hulzen, A.G.W., Kraan, S., Kruiper, M.S.M., Debast, S.B., Wagenvoort, G.H.J., Roukens, A.H.E., de Boer, M.G.J., Jolink, H., Lambregts, M.M.C., Scheper, H., van Holten, N., van der Sluis, D., Claas, E.C.J., Wessels, E., den Hollander, J.G., El Moussaoui, R., Pogany, K., Brouwer, C.J., Heida-Peters, D., Mulder, E., Smit, J.V., Struik-Kalkman, D., van Niekerk, T., Pontesilli, O., van Tienen, C., Lowe, S.H., Oude Lashof, A.M.L., Posthouwer, D., Stoop, A., van Wolfswinkel, M.E., Ackens, R.P., Elasri, M., Houben-Pintaric, K., Schippers, J., Havenith, T.R.A., van Loo, M., van Vonderen, M.G.A., Kampschreur, L.M., Timmer, C., van Broekhuizen, M.C., Faber, S., Al Moujahid, A., Kootstra, G.J., Delsing, C.E., van der Burg-van de Plas, M., Scheiberlich, L., Kortmann, W., van Twillert, G., Renckens, R., Wagenaar, J., Ruiter-Pronk, D., Stander, B., Cohen Stuart, J.W.T., Hoogewerf, M., Rozemeijer, W., Sinnige, J.C., Brinkman, K., van den Berk, G.E.L., Lettinga, K.D., de Regt, M., Schouten, W.E.M., Stalenhoef, J.E., Blaauw, H., Geerders, G.F., Kleene, M.J., Knapen, M., Kok, M., van der Meché, I.B., Toonen, A.J.M., Wijnands, S., Wttewaal, E., Kwa, D., van de Laar, T.J.W., van Crevel, R., van Aerde, K., Dofferhoff, A.S.M., Henriet, S.S.V., ter Hofstede, H.J.M., Hoogerwerf, J., Richel, O., Albers, M., Grintjes-Huisman, K.J.T., de Haan, M., Marneef, M., McCall, M., Rahamat-Langendoen, J., Ruizendaal, E., Burger, D., Gisolf, E.H., Claassen, M., Hassing, R.J., ter Beest, G., van Bentum, P.H.M., Neijland, Y., Valette, M., Swanink, C.M.A., Klein Velderman, M., van Lelyveld, S.F.L., Soetekouw, R., van der Prijt, L.M.M., van der Swaluw, J., Kalpoe, J.S., Wagemakers, A., Vahidnia, A., Lauw, F.N., Verhagen, D.W.M., van Wijk, M., Bierman, W.F.W., Bakker, M., van Bentum, R.A., van den Boomgaard, M.A., Kleinnijenhuis, J., Kloeze, E., Middel, A., Postma, D.F., Schenk, H.M., Stienstra, Y., Wouthuyzen-Bakker, M., Boonstra, A., Maerman, M.M.M., de Weerd, D.A., van Eije, K.J., Knoester, M., van Leer-Buter, C.C., Niesters, H.G.M., Barth, R.E., Bruns, A.H.W., Ellerbroek, P.M., Hensgens, M.P.M., Oosterheert, J.J., Schadd, E.M., Verbon, A., Griffioen-van Santen, B.M.G., de Kroon, I., Schuurman, R., Verduyn Lunel, F.M., Wensing, A.M.J., van der Valk, M., Zaheri, S., Boyd, A.C., Bezemer, D.O., Jongen, V.W., van Sighem, A.I., Smit, C., Wit, F.W.M.N., Hillebregt, M.M.J., Woudstra, T.J., Rutkens, T., Bergsma, D., Brétin, N.M., Koster, L.E., Lelivelt, K.J., van de Sande, L., Schoorl, M.J.C., Visser, K.M., van der Vliet, S.T., Paling, F., van den Akker, M., Akpomukai, O.M., Alexander, R., Bakker, Y.M., Bastos Sales, L., El Berkaoui, A., Bezemer-Goedhart, M., Djoechro, E.A., Grolleman, J.M., El Hammoud, I., Khouw, M.R., Lodewijk, C.R.E., Lucas, E.G.A., van Meerveld-Derks, S., Mulder, H.W., Munjishvili, L., Ree, C.M.J., Regtop, R., van Rijk, A.F., Ruijs-Tiggelman, Y.M.C., Schnörr, P.P., van Veen, R., van Vliet-Klein Gunnewiek, W.H.G., and Witte, E.C.M.
- Abstract
Currently, real-world data on doravirine are scarce. In a national prospective cohort, we assessed the effectiveness and tolerability of switching to doravirine-based antiretroviral therapy (ART) in people with HIV.
- Published
- 2024
- Full Text
- View/download PDF
5. Revealing Glycosylation Patterns in In Vitro-Produced Mucus Exposed to Pasteurized Mucus-Associated Intestinal Microbes by MALDI-TOF-MS and PGC-LC-MS/MS.
- Author
-
de Ram, Carol, van der Lugt, Benthe, Elzinga, Janneke, Geerlings, Sharon, Steegenga, Wilma T., Belzer, Clara, and Schols, Henk A.
- Published
- 2024
- Full Text
- View/download PDF
6. Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study.
- Author
-
Kanning, Jos P., Abtahi, Shahab, Schnier, Christian, Klungel, Olaf H., Geerlings, Mirjam I., and Ruigrok, Ynte M.
- Published
- 2024
- Full Text
- View/download PDF
7. Access to a pre-sleep protein snack increases daily energy and protein intake in surgical hospitalized patients.
- Author
-
Weijzen, Michelle E.G., Kohlen, Maxime, Monsegue, Alejandra, Houtvast, Dion C.J., Nyakayiru, Jean, Beijer, Sandra, Geerlings, Phil, Verdijk, Lex B., and van Loon, Luc J.C.
- Abstract
In hospitalized patients, daily protein intake remains far below WHO requirements for healthy adults (0.8 g·kg
−1 ·d−1 ) as well as ESPEN guidelines for patients (1.2–1.5 g·kg−1 ·d−1 ). Providing access to a pre-sleep protein dense snack between dinner and going to bed may serve as a great opportunity to increase daily energy and protein intake in hospitalized patients. However, it remains to be assessed whether protein provision prior to sleep effectively increases protein intake, or may reduce food intake throughout the remainder of the day(s). The present study evaluated the impact of giving access to a pre-sleep snack on daily energy and protein intake in patients throughout their hospitalization. Patients admitted to the surgical wards of the Maastricht University Medical Centre+ were randomly allocated to usual care (n = 51) or given access to a pre-sleep snack (n = 50). The pre-sleep snack consisted of 103 g cheese cubes (30 g protein) provided between 7:30 and 9:30 PM, prior to sleep. All food provided and all food consumed was weighed and recorded throughout (2–7 days) hospitalization. Daily energy and protein intake and distribution were calculated. Data were analyzed by independent T-Tests with P < 0.05 considered as statistically significant. Daily energy intake was higher in the pre-sleep group (1353 ± 424 kcal d−1 ) when compared to the usual care group (1190 ± 402 kcal·d−1 ; P = 0.049). Providing patients access to a pre-sleep snack resulted in a 17% (11 ± 9 g) higher daily protein intake (0.81 ± 0.29 g·kg−1 ·d−1 ) when compared to the usual care group (0.69 ± 0.28 g·kg−1 ·d−1 ; P = 0.045). Protein intake at breakfast, lunch, and dinner did not differ between the pre-sleep and usual care groups (all P > 0.05). Providing access to a pre-sleep protein snack, in the form of protein dense food items such as cheese, represents an effective dietary strategy to increase daily energy and protein intake in hospitalized patients. Patients consuming pre-sleep protein snacks do not compensate by lowering energy or protein intake throughout the remainder of the days. Pre-sleep protein dense food provision should be implemented in hospital food logistics to improve the nutritional intake of patients. NL8507 (https://trialsearch.who.int/) [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
8. Patient engagement to counter catheter-associated urinary tract infections with an app (PECCA): a multicentre, prospective, interrupted time-series and before-and-after study.
- Author
-
Bentvelsen, R.G., Laan, B.J., Bonten, T., van der Vaart, R., Hetem, D.J., Soetekouw, R., Geerlings, S.E., Chavannes, N.H., and Veldkamp, K.E.
- Abstract
The risk of urinary tract infections (UTIs) is increased by unnecessary placement and prolonged use of urinary catheters. To assess whether inappropriate use of catheters and catheter-associated UTI were reduced through patient participation. In this multicentre, interrupted time-series and before-and-after study, we implemented a patient-centred app which provides catheter advice for patients, together with clinical lessons, feedback via e-mails and support rounds for staff members. Data on catheter use and infections were collected during a six-month baseline and a six-month intervention period on 13 wards in four hospitals in the Netherlands. Dutch Trial Register: NL7178. Between June 25
th , 2018 and August 1st , 2019, 6556 patients were included in 24 point-prevalence surveys, 3285 (50%) at baseline and 3271 (50%) during the intervention. During the intervention 249 app users and a median of seven new app users per week were registered (interquartile range: 5.5–13.0). At baseline, inappropriate catheter use was registered for 175 (21.9%) out of 798 catheters, compared to 55 (7.0%) out of 786 during the intervention. Time-series analysis showed a non-significant decrease of inappropriate use of 5.8% (95% confidence interval: –3.76 to 15.45; P = 0.219), with an odds ratio of 0.27 (0.19–0.37; P < 0.001). Catheter-associated UTI decreased by 3.0% (1.3–4.6; P = 0.001), with odds ratio 0.541 (0.408–0.716; P < 0.001). Although UTI significantly decreased after the implementation, patient participation did not significantly reduce the prevalence of inappropriate urinary catheter use. However, the inappropriate catheter reduction of 5.8% and an odds ratio of 0.27 suggest a positive trend. Patient participation appears to reduce CAUTI and could reduce other healthcare-associated infections. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
9. Revealing Glycosylation Patterns in In Vitro-Produced Mucus Exposed to Pasteurized Mucus-Associated Intestinal Microbes by MALDI-TOF-MS and PGC-LC-MS/MS
- Author
-
de Ram, Carol, van der Lugt, Benthe, Elzinga, Janneke, Geerlings, Sharon, Steegenga, Wilma T., Belzer, Clara, and Schols, Henk A.
- Abstract
The human intestinal mucus layer protects against pathogenic microorganisms and harmful substances, whereas it also provides an important colonization niche for mutualistic microbes. The main functional components of mucus are heavily glycosylated proteins, called mucins. Mucins can be cleaved and utilized by intestinal microbes. The mechanisms between intestinal microbes and the regulation of mucin glycosylation are still poorly understood. In this study, in vitromucus was produced by HT29-MTX-E12 cells under Semi-Wet interface with Mechanical Stimulation. Cells were exposed to pasteurized nonpathogenic bacteria Akkermansia muciniphila, Ruminococcus gnavus, and Bacteroides fragilisto evaluate influence on glycosylation patterns. Following an optimized protocol, O- and N-glycans were efficiently and reproducibly released, identified, and semiquantified using MALDI-TOF-MS and PGC-LC-MS/MS. Exposure of cells to bacteria demonstrated increased diversity of sialylated O-glycans and increased abundance of high mannose N-glycans in in vitroproduced mucus. Furthermore, changes in glycan ratios were observed. It is speculated that bacterial components interact with the enzymatic processes in glycan production and that pasteurized bacteria influence glycosyltransferases or genes involved. These results highlight the influence of pasteurized bacteria on glycosylation patterns, stress the intrinsic relationship between glycosylation and microbiota, and show the potential of using in vitroproduced mucus to study glycosylation behavior.
- Published
- 2024
- Full Text
- View/download PDF
10. Theoretical Study on the Regioselectivity of Leapfrog B18 and B30 Boron Sheets in Electrophilic and Nucleophilic Reactions Using DFT-Based Reactivity Indices.
- Author
-
Muya, Jules Tshishimbi and Geerlings, Paul
- Published
- 2024
- Full Text
- View/download PDF
11. Extending the Scope of Conceptual Density Functional Theory with Second Order Analytical Methodologies.
- Author
-
Wang, Bin, Geerlings, Paul, Liu, Shubin, and De Proft, Frank
- Published
- 2024
- Full Text
- View/download PDF
12. Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer
- Author
-
Tolmeijer, Sofie H., van Wilpe, Sandra, Geerlings, Maartje J., von Rhein, Daniel, Smilde, Tineke J., Kloots, Iris S.H., Westdorp, Harm, Coskuntürk, Mustafa, Oving, Irma M., van Ipenburg, Jolique A., van der Heijden, Antoine G., Hofste, Tom, Weiss, Marjan M., Schalken, Jack A., Gerritsen, Winald R., Ligtenberg, Marjolijn J.L., and Mehra, Niven
- Abstract
Early changes in circulating tumor DNA (ctDNA) levels during immunotherapy strongly associate with therapy response and survival of patients with advanced urothelial cancer. These results justify prospective studies to evaluate switching or intensifying therapy based on early on-treatment ctDNA changes.
- Published
- 2024
- Full Text
- View/download PDF
13. Extending the Scope of Conceptual Density Functional Theory with Second Order Analytical Methodologies
- Author
-
Wang, Bin, Geerlings, Paul, Liu, Shubin, and De Proft, Frank
- Abstract
In the context of the growing impact of conceptual density functional theory (DFT) as one of the most successful chemical reactivity theories, response functions up to second order have now been widely applied; in recent years, among others, particular attention has been focused on the linear response function and also extensions to higher order have been put forward. As the larger part of these studies have been carried using a finite difference approach to compute these concepts, we now embarked on (an extension of) an analytical approach to conceptual DFT. With the ultimate aim of providing a complete set of analytically computable second order properties, including the softness and hardness kernels, the hardness as the simplest second order response function is scrutinized again with numerical results highlighting the difference in nature between the analytical hardness (referred to as hardness condition) and the Parr-Pearson absolute chemical hardness. The hardness condition is investigated for its capability to gauge the (de)localization error of density functional approximations (DFAs). The analytical Fukui function, besides overcoming the difficulties in the finite difference approach in treating negatively charged systems, also showcases the errors of deviating from the straight-line behavior using fractional occupation number calculations. Subsequently, the softness kernel and its atom-condensed inverse, the hardness matrix, are accessed through the Berkowitz-Parr relation. Revisiting the softness kernel confirms and extends previous discussions on how Kohn’s Nearsightedness of Electronic Matter principle can be retrieved and identified as the physicist’s version of the chemist’s “transferability of functional groups” concept. The accurate, analytical hardness matrix evaluation on the other hand provides further support for the basics of Nalewajski’s charge sensitivity analysis. Based on Parr and Liu’s functional expansion of the energy functional, a new energy decomposition is introduced with an order of magnitude analysis of the different terms for a series of simple molecules both at their equilibrium geometry and upon variation in bond length and dihedral angle. Finally, for the first time, the perturbation expansion of the energy functional is studied numerically up to second order now that all response functions and integration techniques are at hand. The perturbation expansion energies are in excellent agreement with those obtained directly from DFA calculations giving confidence in the convergence of the perturbation series and its use in judging the importance of the different terms in reactivity investigations.
- Published
- 2024
- Full Text
- View/download PDF
14. Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions: A MR CLEAN Registry Study
- Author
-
Knapen, Robrecht R.M.M., Pirson, F. Anne V., Langezaal, Lucianne C.M., Brouwer, Josje, Majoie, Charles B.L.M., Emmer, Bart J., Vos, Jan-Albert, van Doormaal, Pieter-Jan, Yoo, Albert J., Bruggeman, Agnetha A.E., Lycklama à Nijeholt, Geert J., van der Leij, Chirstiaan, van Oostenbrugge, Robert J., van Zwam, Wim H., Schonewille, Wouter J., Dippel, Diederik W.J., van der Lugt, Aad, Roos, Yvo B.W.E.M., Boiten, Jelis, Jansen, Ivo G.H., Mulder, Maxim J.H.L., Goldhoorn, Robert-Jan B., Compagne, Kars C.J., Kappelhof, Manon, den Hartog, Sanne J., Hinsenveld, Wouter H., Dippel, Diederik W.J., Roozenbeek, Bob, van der Lugt, Aad, Roos, Yvo B.W.E.M., Wermer, Marieke J.H., van Walderveen, Marianne A.A., van Es, Adriaan C.G.M., Staals, Julie, Hofmeijer, Jeannette, Martens, Jasper M., Boiten, Jelis, de Bruijn, Sebastiaan F., van Dijk, Lukas C., Bart van der Worp, H., Lo, Rob H., van Dijk, Ewoud J., Boogaarts, Hieronymus D., de Vries, J., de Kort, Paul L.M., van Tuijl, Julia, Peluso, Jo P., Fransen, Puck, van den Berg, Jan S.P., van Hasselt, Boudewijn A.A.M., Aerden, Leo A.M., Dallinga, René J., Uyttenboogaart, Maarten, Eschgi, Omid, Bokkers, Reinoud P.H., Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Keizer, Koos, Yo, Lonneke S.F., den Hertog, Heleen M., Sturm, Emiel J.C., Brouwers, Paul J.A.M., van Walderveen, Marianne A.A., Sprengers, Marieke E.S., Jenniskens, Sjoerd F.M., van den Berg, René, Beenen, Ludo F.M., Postma, Alida A., Roosendaal, Stefan D., van der Kallen, Bas F.W., van den Wijngaard, Ido R., van Es, Adriaan C.G.M., Martens, Jasper M., Yo, Lonneke S.F., Bot, Joost, Meijer, Anton, Ghariq, Elyas, Bokkers, Reinoud P.H., van Proosdij, Marc P., Menno Krietemeijer, G., Peluso, Jo P., Boogaarts, Hieronymus D., Lo, Rob, Dinkelaar, Wouter, Appelman, Auke P.A., Hammer, Bas, Pegge, Sjoert, van der Hoorn, Anouk, Vinke, Saman, Cornelissen, Sandra, Brans, Rutger, Dippel, Diederik W.J., van der Lugt, Aad, Roos, Yvo B.W.E.M., Boiten, Jelis, Hofmeijer, Jeannette, Martens, Jasper M., Bart van der Worp, H., Lo, Rob H., Hofmeijer, Jeannette, Zwenneke Flach, H., Lingsma, Hester F., el Ghannouti, Naziha, Sterrenberg, Martin, Pellikaan, Wilma, Sprengers, Rita, Elfrink, Marjan, Simons, Michelle, Vossers, Marjolein, de Meris, Joke, Vermeulen, Tamara, Geerlings, Annet, van Vemde, Gina, Simons, Tiny, Messchendorp, Gert, Nicolaij, Nynke, Bongenaar, Hester, Bodde, Karin, Kleijn, Sandra, Lodico, Jasmijn, Droste, Hanneke, Wollaert, Maureen, Verheesen, Sabrina, Jeurrissen, D., Bos, Erna, Drabbe, Yvonne, Sandiman, Michelle, Aaldering, Nicoline, Zweedijk, Berber, Vervoort, Jocova, Ponjee, Eva, Romviel, Sharon, Kanselaar, Karin, Barning, Denn, Venema, Esmee, Chalos, Vicky, Geuskens, Ralph R., van Straaten, Tim, Ergezen, Saliha, Harmsma, Roger R.M., Muijres, Daan, de Jong, Anouk, Berkhemer, Olvert A., Boers, Anna M.M., Huguet, J., Groot, P.F.C., Mens, Marieke A., van Kranendonk, Katinka R., Treurniet, Kilian M., Tolhuisen, Manon L., Alves, Heitor, Weterings, Annick J., Kirkels, Eleonora L.F., Voogd, Eva J.H.F., Schupp, Lieve M., Collette, Sabine L., Groot, Adrien E.D., LeCouffe, Natalie E., Konduri, Praneeta R., Prasetya, Haryadi, Arrarte-Terreros, Nerea, Ramos, Lucas A., and Boodt, Nikki
- Published
- 2024
- Full Text
- View/download PDF
15. The effect of an intervention bundle to prevent central venous catheter-related bloodstream infection in a national programme in the Netherlands.
- Author
-
van der Kooi, T.I.I., Smid, E.A., Koek, M.B.G., Geerlings, S.E., Bode, L.G.M., Hopmans, T.E.M., de Greeff, S.C., van der Kooi, Tjallie I I, Smid, Emma A, Koek, Mayke B G, Geerlings, Suzanne E, Bode, Lonneke G M, Hopmans, Titia E M, and de Greeff, Sabine C
- Abstract
Introduction: Central venous catheters (CVCs) can lead to central line-related bloodstream infections (CRBSI). A six-item bundle was introduced in 2009 to prevent CRBSI in Dutch hospitals.Aim: This study aimed to determine the impact of an intervention bundle on CRBSI risk.Methods: Data were obtained from hospitals participating in the national CRBSI surveillance between 2009 and 2019. Bundle compliance was evaluated as a total ("overall") bundle (all six items) and as an insertion bundle (four items) and a maintenance bundle (two daily checks). We estimated the impact of the overall and partial bundles, using multilevel Cox regression.Findings: Of the 66 hospitals in the CRBSI surveillance 56 (84.8%) recorded annual bundle (non)compliance for >80% of the CVCs, for 1-9 years. In these 56 hospitals CRBSI incidence decreased from 4.0 to 1.6/1000 CVC days. In the intensive care units (ICU) compliance was not associated with CRBSI risk (hazard ratio (HR) for the overall, insertion and maintenance bundle were 1.14 [95% confidence interval 0.80-1.64], 1.05 [0.56-1.95] and 1.13 [0.79-1.62]), respectively. Outside the ICU the non-significant association of compliance with the overall bundle (HR 1.36 [0.96-1.93]) resulted from opposite effects of the insertion bundle, associated with decreased risk (HR 0.50 [0.30-0.85]) and the maintenance bundle, associated with increased risk (HR 1.68 [1.19-2.36]).Conclusion: Following a national program to introduce an intervention bundle CRBSI incidence decreased significantly. In the ICU bundle compliance was not associated with CRBSI risk, but outside the ICU improved compliance to the insertion bundle resulted in a decreased CRBSI risk. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
16. Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential
- Author
-
Ioannou, Athanasia, Berkhout, Maryse D., Geerlings, Sharon Y., and Belzer, Clara
- Abstract
Akkermansia muciniphilais a gut bacterium that colonizes the gut mucosa, has a role in maintaining gut health and shows promise for potential therapeutic applications. The discovery of A. muciniphilaas an important member of our gut microbiome, occupying an extraordinary niche in the human gut, has led to new hypotheses on gut health, beneficial microorganisms and host–microbiota interactions. This microorganism has established a unique position in human microbiome research, similar to its role in the gut ecosystem. Its unique traits in using mucin sugars and mechanisms of action that can modify host health have made A. muciniphilaa subject of enormous attention from multiple research fields. A. muciniphilais becoming a model organism studied for its ability to modulate human health and gut microbiome structure, leading to commercial products, a genetic model and possible probiotic formulations. This Review provides an overview of A. muciniphilaand Akkermansiagenus phylogeny, ecophysiology and diversity. Furthermore, the Review discusses perspectives on ecology, strategies for harnessing beneficial effects of A. muciniphilafor human mucosal metabolic and gut health, and its potential as a biomarker for diagnostics and prognostics.
- Published
- 2024
- Full Text
- View/download PDF
17. Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer.
- Author
-
Hofste, Lisa S.M., Geerlings, Maartje J., von Rhein, Daniel, Rütten, Heidi, Westenberg, A. Helen, Weiss, Marjan M., Gilissen, Christian, Hofste, Tom, van der Post, Rachel S., Klarenbeek, Bastiaan R., de Wilt, Johannes H.W., and Ligtenberg, Marjolijn J.L.
- Subjects
RECTAL cancer ,CIRCULATING tumor DNA ,NEOADJUVANT chemotherapy ,DISEASE relapse ,NUCLEOTIDE sequencing ,PROGRESSION-free survival - Abstract
Patients with early-stage and locally advanced rectal cancer are often treated with neoadjuvant therapy followed by surgery or watch and wait. This study evaluated the role of circulating tumor DNA (ctDNA) to measure disease after neoadjuvant treatment and surgery to optimize treatment choices. Patients with rectal cancer treated with both chemotherapy and radiotherapy were included and diagnostic biopsies were analyzed for tumor-specific mutations. Presence of ctDNA was measured in plasma by tracing the tumor-informed mutations using a next-generation sequencing panel. The association between ctDNA detection and clinicopathological characteristics and progression-free survival was measured. Before treatment ctDNA was detected in 69% (35/51) of patients. After neoadjuvant therapy ctDNA was detected in only 15% (5/34) of patients. In none of the patients with a complete clinical response who were selected for a watch and wait strategy (0/10) or patients with ypN0 disease (0/8) ctDNA was detected, whereas it was detected in 31% (5/16) of patients with ypN + disease. After surgery ctDNA was detected in 16% (3/19) of patients, of which all (3/3) developed recurrent disease compared to only 13% (2/16) in patients with undetected ctDNA after surgery. In an exploratory survival analysis, both ctDNA detection after neoadjuvant therapy and after surgery was associated with worse progression-free survival (p = 0.01 and p = 0.007, respectively, Cox-regression). These data show that in patients with early-stage and locally advanced rectal cancer tumor-informed ctDNA detection in plasma using ultradeep sequencing may have clinical value to complement response prediction after neoadjuvant therapy and surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Investigating the Linear Response Function under Approximations Following the Coupled-Perturbed Approach for Atoms and Molecules.
- Author
-
Wang, Bin, Geerlings, Paul, Van Alsenoy, Christian, Heider-Zadeh, Farnaz, Ayers, Paul W., and De Proft, Frank
- Published
- 2023
- Full Text
- View/download PDF
19. Alzheimer's disease plasma markers and depressive symptoms: an IPD meta‐analysis.
- Author
-
Twait, Emma L., Kamarioti, Maria, Verberk, Inge M.W., Teunissen, Charlotte E., Nooyens, Astrid C.J., Verschuren, Monique WM, Visser, Pieter Jelle, Huisman, Martijn, Kok, Almar A.L., Slagboom, P. Eline, Beekman, Marian, Ikram, M. Arfan, Schuurmans, Isabel K, Wolters, Frank J., Moonen, Justine E., Gerritsen, Lotte, van der Flier, Wiesje M., and Geerlings, Mirjam I.
- Abstract
Background: Depression has been associated with an increased risk of Alzheimer's disease (AD), but the biological mechanisms are still not fully understood. Plasma biomarkers, such as amyloid‐beta, tau, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL), have been associated with AD pathophysiology. However, the relationship with depression is unclear. Assessing these biomarkers in the blood allows for the opportunity to assess if AD pathology is related to depressive symptoms on a large‐scale. We hypothesized if depression is part of the AD process, then these markers will be associated with depressive symptoms. Method: A two‐stage IPD meta‐analysis was performed based on eight cohorts of individuals without dementia as part of the Netherlands Consortium of Dementia Cohorts (NCDC). We examined the cross‐sectional association between each plasma marker for AD (amyloid‐beta42/40 ratio, p‐tau181, NfL, and GFAP) with depressive symptoms (the GDS‐15, PHQ‐9, CES‐D, and SF‐36). Plasma markers were assessed using Single Molecular Array (Simoa; Quanterix) assays. Both plasma markers and depressive symptoms were standardized. We estimated the effect per plasma marker with depressive symptoms using linear regressions, correcting for age, sex, education, and APOE e4 allele presence, in each cohort. The effect estimates were entered into a random‐effects meta‐analysis. We also performed subgroup analyses assessing sex differences and between those with and without an APOE e4 allele. Result: This study involved 7210 participants with an age range of 38 to 102 years. Based on clinical cut‐offs per questionnaire, high depressive symptomology ranged from one to 22% per cohort. None of the plasma markers were associated with depressive symptoms in the meta‐analysis. However, subgroup analyses found an association with NfL and depressive symptoms in women (beta 0.07; 95% CI: 0.03‐0.10, p < 0.001) and in those with an APOE e4 allele (beta 0.11; 95% CI: 0.05‐0.17, p = 0.001). Conclusion: AD pathology did not show an overall relationship with depressive symptoms. However, in women and in those with a genetic risk for AD, NfL showed an association. As NfL is a marker of overall neurodegeneration, this pathology in plasma may be specific to depressive symptoms in certain subgroups. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Mechanochemical Felkin–Anh Model: Achieving Forbidden Reaction Outcomes with Mechanical Force.
- Author
-
Bettens, Tom, Alonso, Mercedes, Geerlings, Paul, and De Proft, Frank
- Published
- 2023
- Full Text
- View/download PDF
21. Investigating the Linear Response Function under Approximations Following the Coupled-Perturbed Approach for Atoms and Molecules
- Author
-
Wang, Bin, Geerlings, Paul, Van Alsenoy, Christian, Heider-Zadeh, Farnaz, Ayers, Paul W., and De Proft, Frank
- Abstract
The linear response kernel also referred to as linear response function (LRF) in the framework of conceptual density functional theory has gained tremendous success in time-dependent density functional theory. Comparatively less attention has been devoted to the LRF from a chemical reactivity perspective in its time- or frequency-independent context, although it has recently been used to qualitatively describe electron delocalization, (anti-)aromaticity, inductive and mesomeric effects, etc. Despite these successes, which were obtained by approximating the LRF using the independent particle approximation deriving from a coupled-perturbed Kohn–Sham computation, the robustness of this LRF approach needs to be assessed. In this work, we compute the LRF at four levels of approximation (independent particle approximation, random phase approximation, Hartree–Fock approximation, and the (exact) DFT (density functional theory) expression) using functionals from the first four rungs of Jacob’s ladder of exchange-correlation energy functionals. To scrutinize the impact of these approximations, new visualization strategies are discussed and systematized. The overall conclusion is that the independent particle approximation yields qualitatively correct results (ergo previous conceptual applications of the LRF are trustworthy), but for quantitative results, LRF expressions including coulomb and exchange(-correlation) terms should be included. With respect to functionals, density-gradient contributions to the exchange-correlation kernel are less than 10% and may be omitted safely where that is preferable computationally.
- Published
- 2023
- Full Text
- View/download PDF
22. Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases
- Author
-
Hofste, Lisa S.M., Geerlings, Maartje J., Kamping, Eveline J., Kouwenhoven, Nadine D.H., von Rhein, Daniel, Jansen, Erik A.M., Garms, Linda M., Nagtegaal, Iris D., van der Post, Rachel S., de Wilt, Johannes H.W., Klarenbeek, Bastiaan R., and Ligtenberg, Marjolijn J.L.
- Published
- 2023
- Full Text
- View/download PDF
23. Effects of Multisession Transcranial Direct Current Stimulation on Stress Regulation and Emotional Working Memory: A Randomized Controlled Trial in Healthy Military Personnel
- Author
-
Smits, Fenne M., Geuze, Elbert, de Kort, Guido J., Kouwer, Karlijn, Geerlings, Lisa, van Honk, Jack, and Schutter, Dennis J.L.G.
- Abstract
Top-down stress regulation, important for military operational performance and mental health, involves emotional working memory and the dorsolateral prefrontal cortex (DLPFC). Multisession transcranial direct current stimulation (tDCS) applied over the DLPFC during working memory training has been shown to improve working memory performance. This study tested the hypothesis that combined tDCS with working memory training also improves top-down stress regulation. However, tDCS response differs between individuals. Resting-state electrophysiological brain activity was post hoc explored as a possible predictor of tDCS response. The predictive value of the ratio between slow-wave theta oscillations and fast-wave beta oscillations (theta/beta ratio) was examined, together with the previously identified tDCS response predictors age, education, and baseline working memory performance.
- Published
- 2023
- Full Text
- View/download PDF
24. Ischemic stroke recurrence and mortality in different imaging phenotypes of ischemic cerebrovascular disease: The SMART-MR Study
- Author
-
Lucci, Carlo, Rissanen, Ina, de Jong, Pim A, Kappelle, L Jaap, Hendrikse, Jeroen, and Geerlings, Mirjam I
- Abstract
Background: Diagnosis of cerebrovascular disease is based on both clinical and radiological findings, however, they do not always correlate.Aims: To investigate ischemic stroke recurrence and mortality in patients with different imaging phenotypes of ischemic cerebrovascular disease.Methods: Within the SMART-MR study, a prospective patient cohort with arterial disease, cerebrovascular diseases of participants at baseline were classified as no cerebrovascular disease (reference group, n= 828), symptomatic cerebrovascular disease (n= 204), covert vascular lesions (n= 156), or imaging negative ischemia (n= 90) based upon clinical and MRI findings. Ischemic strokes and deaths were collected at 6 month-intervals up to 17 years of follow-up. With Cox regression, relationships between phenotype and ischemic stroke recurrence, cardiovascular mortality, and non-vascular mortality were studied adjusted for age, sex, and cardiovascular risk factors.Results: Compared to reference group risk for recurrent ischemic stroke was increased not only in the symptomatic cerebrovascular disease (HR 3.9, 95% CI 2.3–6.6), but also in the covert vascular lesion (HR 2.5, 95% CI 1.3–4.8) and the imaging negative ischemia groups (HR 2.4, 95% CI 1.1–5.5). Risk for cardiovascular mortality was increased in the symptomatic cerebrovascular disease (HR 2.2, 95% CI 1.5–3.2) and covert vascular lesions groups (HR 2.3, 95% CI 1.5–3.4), while the risk was less strong but also increased in the imaging negative ischemia group (HR 1.7, 95% CI 0.9–3.0).Conclusions: People with all imaging phenotypes of cerebrovascular disease have increased risk of recurrent ischemic stroke and mortality compared to other arterial diseases. Strict preventive measures should be performed even when imaging findings or clinical symptoms are absent.Data access statement: For use of anonymized data, a reasonable request has to be made in writing to the UCC-SMART study group and the third party has to sign a confidentiality agreement.
- Published
- 2023
- Full Text
- View/download PDF
25. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice
- Author
-
van Voorst, Henk, Bruggeman, Agnetha A.E., Andriessen, Jurr, Hoving, Jan W., Konduri, Praneeta R., Yang, Wenjin, Kappelhof, Manon, Arrarte Terreros, Nerea, Roos, Yvo B.W.E.M., van Zwam, Wim H., van der Lugt, Aad, van der Hoorn, Anouk, Boiten, Jelis, Roosendaal, Stefan, Jenniskens, Sjoerd, Caan, Matthan W.A., Marquering, Henk A., Emmer, Bart J., Majoie, Charles B.L.M., Dippel, Diederik W.J., van Oostenbrugge, Robert J., Vos, Jan Albert, Jansen, Ivo G.H., Mulder, Maxim J.H.L., Goldhoorn, Robert- Jan B., Compagne, Kars C.J., Brouwer, Josje, den Hartog, Sanne J., Hinsenveld, Wouter H., Dippel, Diederik W.J., Roozenbeek, Bob, van Es, Adriaan C.G.M., Coutinho, Jonathan M., Schonewille, Wouter J., Vos, Jan Albert, Wermer, Marieke J.H., van Walderveen, Marianne A.A., Staals, Julie, van Oostenbrugge, Robert J., Hofmeijer, Jeannette, Martens, Jasper M., Lycklama à Nijeholt, Geert J., de Bruijn, Sebastiaan F., van Dijk, Lukas C., van der Worp, H. Bart, Lo, Rob H., van Dijk, Ewoud J., Boogaarts, Hieronymus D., de Vries, J., de Kort, Paul L.M., van Tuijl, Julia, Peluso, Jo P., Fransen, Puck, van den Berg, Jan S.P., van Hasselt, Boudewijn A.A.M., Aerden, Leo A.M., Dallinga, René J., Uyttenboogaart, Maarten, Eschgi, Omid, Bokkers, Reinoud P.H., Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Keizer, Koos, Yo, Lonneke S.F., den Hertog, Heleen M., Sturm, Emiel J.C., Brouwers, Paul J.A.M., Lycklama à Nijeholt, Geert J., van Walderveen, Marianne A.A., Sprengers, Marieke E.S., van den Berg, René, Yoo, Albert J., Beenen, Ludo F.M., Postma, Alida A., van der Kallen, Bas F.W., van den Wijngaard, Ido R., van Es, Adriaan C.G.M., Martens, Jasper M., Yo, Lonneke S.F., Vos, Jan Albert, Bot, Joost, van Doormaal, Pieter-Jan, Meijer, Anton, Ghariq, Elyas, Bokkers, Reinoud P.H., van Proosdij, Marc P., Krietemeijer, G. Menno, Peluso, Jo P., Boogaarts, Hieronymus D., Lo, Rob, Gerrits, Dick, Dinkelaar, Wouter, Appelman, Auke P.A., Hammer, Bas, Pegge, Sjoert, Vinke, Saman, Dippel, Diederik W.J., van Oostenbrugge, Robert J., Lycklama à Nijeholt, Geert J., Vos, Jan Albert, Schonewille, Wouter J., Hofmeijer, Jeannette, Martens, Jasper M., van der Worp, H. Bart, Lo, Rob H., van Oostenbrugge, Robert J., Hofmeijer, Jeannette, Flach, H. Zwenneke, Lingsma, Hester F., el Ghannouti, Naziha, Sterrenberg, Martin, Pellikaan, Wilma, Sprengers, Rita, Elfrink, Marjan, Simons, Michelle, Vossers, Marjolein, de Meris, Joke, Vermeulen, Tamara, Geerlings, Annet, van Vemde, Gina, Simons, Tiny, Messchendorp, Gert, Nicolaij, Nynke, Bongenaar, Hester, Bodde, Karin, Kleijn, Sandra, Lodico, Jasmijn, Droste, Hanneke, Wollaert, Maureen, Verheesen, Sabrina, Jeurrissen, D., Bos, Erna, Drabbe, Yvonne, Sandiman, Michelle, Aaldering, Nicoline, Zweedijk, Berber, Vervoort, Jocova, Ponjee, Eva, Romviel, Sharon, Kanselaar, Karin, Barning, Denn, Venema, Esmee, Chalos, Vicky, Geuskens, Ralph R., van Straaten, Tim, Ergezen, Saliha, Harmsma, Roger R.M., Muijres, Daan, de Jong, Anouk, Berkhemer, Olvert A., Boers, Anna M.M., Huguet, J., Groot, P.F.C., Mens, Marieke A., van Kranendonk, Katinka R., Treurniet, Kilian M., Tolhuisen, Manon L., Alves, Heitor, Weterings, Annick J., Kirkels, Eleonora L.F., Voogd, Eva J.H.F., Schupp, Lieve M., Collette, Sabine, Groot, Adrien E.D., LeCouffe, Natalie E., Prasetya, Haryadi, and Ramos, Lucas A.
- Published
- 2023
- Full Text
- View/download PDF
26. Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study
- Author
-
Verheij, Eveline, Boyd, Anders, Wit, Ferdinand W, Verboeket, Sebastiaan O, Verburgh, Myrthe L, van der Valk, Marc, Schim van der Loeff, Maarten F, Reiss, Peter, Reiss, P., Wit, F.W.N.M., van der Valk, M., Schouten, J., Kooij, K.W., van Zoest, R.A., Verheij, E., Verboeket, S.O., Elsenga, B.C., Prins, M., Schim van der Loeff, M.F., del Grande, L., Olthof, V., Agard, I., Zaheri, S., Hillebregt, M.M.J., Ruijs, Y.M.C., Benschop, D.P., el Berkaoui, A., Kootstra, N.A., Harskamp-Holwerda, A.M., Maurer, I., Mangas Ruiz, M.M., Girigorie, A.F., Boeser-Nunnink, B., Zikkenheiner, W., Nolst Trenité, S., Geerlings, S.E., Goorhuis, A., Hovius, J.W.R., Nellen, F.J.B., van der Poll, T., Prins, J.M., Wiersinga, W.J., van Vugt, M., de Bree, G., van Eden, J., van Hes, A.M.H., Pijnappel, F.J.J., Weijsenfeld, A., Smalhout, S., van Duinen, M., Hazenberg, A., Postema, P.G., Bisschop, P.H.L.T., Serlie, M.J.M., Lips, P., Dekker, E., Dekker, N., Willemsen, J.M.R., and Vogt, L.
- Abstract
People with HIV generally have more ageing-associated comorbidities than those without HIV. We aimed to establish whether the difference in comorbidities and their disease burden changes with ageing.
- Published
- 2023
- Full Text
- View/download PDF
27. Mechanochemical Felkin–Anh Model: Achieving Forbidden Reaction Outcomes with Mechanical Force
- Author
-
Bettens, Tom, Alonso, Mercedes, Geerlings, Paul, and De Proft, Frank
- Abstract
Anti-Felkin–Anh diastereoselectivity can be achieved for nucleophilic additions to α-chiral ketones upon stretching the ketone with a mechanical pulling force. Herein, a mechanochemical Felkin–Anh model is proposed for predicting the outcome of a nucleophilic addition to an α-chiral ketone. Essentially, the fully stretched chiral ketone has one substituent shielding each side of the carbonyl, in contrast to the Felkin–Anh model, in which free rotation around a bond is required to achieve the two rotamers of the ketone. Depending on the pulling scenario, either Felkin–Anh or anti-Felkin–Anh diastereoselectivity is obtained. The model is entirely based on the distance between the pulling points, which is maximized in the anti-periplanar arrangement. The major diastereomer is associated with the approach with the least steric interactions. The intuitive model is validated by means of mechanochemical density functional theory calculations. Importantly, the ketone is fully stretched in the sub 1 nN force regime, thus minimizing the risk of undesired homolytic bond rupture. Moreover, the mechanical force is not used for lowering the reaction barriers associated with the nucleophilic addition; instead, it is solely applied for locking the conformation of a molecule and provoking otherwise inaccessible reaction pathways on the force-modified potential energy surface.
- Published
- 2023
- Full Text
- View/download PDF
28. Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass
- Author
-
Chen, Rou Qing, Zino, Leena, Geerlings, Suzanne, Colbers, Angela, and Burger, David
- Published
- 2023
- Full Text
- View/download PDF
29. A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice
- Author
-
Kramer, Astrid, Schuuring, Ed, Vessies, Daan C.L., van der Leest, Paul, Geerlings, Maartje J., Rozendal, Pim, Lanfermeijer, Mirthe, Linders, Theodora C., van Kempen, Léon C., Fijneman, Remond J.A., Ligtenberg, Marjolijn J.L., Meijer, Gerrit A., van den Broek, Daan, Retèl, Valesca P., and Coup, Veerle M.H.
- Abstract
Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursement and implementation, but challenging because of variations in workflow. We aimed to develop a micro-costing framework for consistent cost calculation of ctDNA testing. First, the foundation of the framework was built, based on the complete step-wise diagnostic workflow of ctDNA testing. Second, the costing method was set up, including costs for personnel, materials, equipment, overhead, and failures. Third, the framework was evaluated by experts and applied to six case studies, including PCR-, mass spectrometry–, and next-generation sequencing–based platforms, from three Dutch hospitals. The developed ctDNA micro-costing framework includes the diagnostic workflow from blood sample collection to diagnostic test result. The framework was developed from a Dutch perspective and takes testing volume into account. An open access tool is provided to allow for laboratory-specific calculations to explore the total costs of ctDNA testing specific workflow parameters matching the setting of interest. It also allows to straightforwardly assess the impact of alternative prices or assumptions on the cost per sample by simply varying the input parameters. The case studies showed a wide range of costs, from €168 to €7638 ($199 to $9124) per sample, and generated information. These costs are sensitive to the (coverage of) platform, setting, and testing volume.
- Published
- 2023
- Full Text
- View/download PDF
30. The energetic relationship between ports and cities;how the role of shared values is under pressure
- Author
-
Vroomans, Jos, Geerlings, Harry, and Kuipers, Bart
- Abstract
•To have an interest in the interrelationships between the actors of the cluster from the perspective of governance and institutional arrangements, helps to overcome the comment that differences are a result in path dependency.•Of course, as said, there is path dependency.•Events in the past do have their influence on later developments.•But these events are rooted themselves in certain conditions.•The path of the cluster is characterized by events and crossings.•In this paper these are the general dynamics.•These dynamics have an effect.•But the feedback on these crossings is influenced by the factors as operationalized by the sensitizing concepts researched in this paper.•They can be linked to the existence of different political economic structures that make up the institutional arrangements that together make up for the existence of shared values.•These differences, often stemming from the past, could be partly explanatory for differences in the appearance of these sensitizing concepts.
- Published
- 2022
- Full Text
- View/download PDF
31. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
- Author
-
Bistervels, Ingrid M, Buchmüller, Andrea, Wiegers, Hanke M G, Ní Áinle, Fionnuala, Tardy, Bernard, Donnelly, Jennifer, Verhamme, Peter, Jacobsen, Anne F, Hansen, Anette T, Rodger, Marc A, DeSancho, Maria T, Shmakov, Roman G, van Es, Nick, Prins, Martin H, Chauleur, Céline, Middeldorp, Saskia, van den Akker, Eline S, Bekker, Mireille N, van Bemmel, Thomas, Bertoletti, Laurent, Blanc, Julie, Bleker, Suzanne M, Bourtembourg-Matras, Aude, Bretelle, Florence, Byrne, Bridgette, Couturaud, Francis, Delorme, Pierre, Eerenberg, Elise S, Franssen, Maureen TM, Fuglsang, Jens, Ganzevoort, Wessel, Goffinet, François, de Haan-Jebbink, Jiska M, Heidema, Wieteke, Hertzberg, Monique A, Hovens, Marcel MC, Huisman, Menno V, de Jong-Speksnijder, Leonie, Kamphuisen, Pieter-Willem, O'Keeffe, Denis J, Lacut, Karine, Langenveld, Josje, Lunshof, M Simone, Martens, Caroline P, Merah, Adel, Le Moigne, Emmanuelle, Papatsonis, Dimitri NM, Pernod, Gilles, Perrotin, Franck, Peynaud-Debayle, Edith, Pierre, Fabrice, Plu Bureau, Geneviève, Raia-Barjat, Tiphaine, Rijnders, Robbert JP, Rosario, Roger, Ruivard, Marc, Schmidt, Jeannot, Sueters, Marieke, Vanassche, Thomas, Varlet, Marie-Noëlle, Vivanti, Alexandre J, van der Vlist, Matthieu Y, van der Voet, Lucet F, Vollebregt, Karlijn C, de Vries, Johanna IP, de Weerd, Sabina, Westerweel, Peter E, Wijnberger, Lia DE, ten Wolde, Marije, Ypma, Paula F, Zuily-Lamy, Catherine, Zwart, Joost J, Benachi, Alexandra, Beucher, Gaël, Bezanahary, Holy, de Boer, Karin, de Boer, Marjon A., Bousquet, Frantz, Bremer, Henk A., Bressollette, Luc, Brossard, Aurélie, Chau, Cécile, Cleary, Brian, Comte, Fabienne, Corsini, Thomas, Coustel, Anne, Debaveye, Barbara, Desbrière, Raoul, Duvillard, Cécile, Eckman, Astrid, Eikenboom, Jeroen, Elias, Antoine, Faber, Laura M., Ferrari, Emile, Gallot, Denis, Gauchotte, Emilie, Gaugler, Ingrid, Geerlings, Abby E., O'Gorman, Audrey, Grobost, Vincent, de Groot, Pieter-Kees, van der Ham, David P., Hermsen, Brenda, Kamphorst, Kim, Karovitch, Alan, Kleiverda, Gunilla, Kloster, Aiste, Koops, Annemarieke, Krabbendam, Inneke, Kruip, Marieke J.H.A., Kuipers, Saskia, van Laar, Judith, Laneelle, Damien, Lima, Suzanne, MacMahon, Peter, Mandelbrot, Laurent, van Meir, Claudia A., Menez, Caroline, Morssink, Leonard P., Moulin, Nathalie, Mousty, Eve, Muller, Matthieu, Murphy, Lucy, Peerlinck, Kathelijne, O'Reilly, Alma, de Reus, Maartje, Le Roux, Magali Hilmi, Ryan, Kevin, Samren, Bettina, Schippers, Daniela, Schuitemaker, Nico, Schweizer, Chloé, van der Straaten, Hanneke, Tromeur, Cécile, Vanheule, Kristine, Verhagen, Tamara, Visser, Jantien, Watts, Michael, van Wijngaarden, Wim J., Woiski, Mallory, and Zelis, Maartje
- Abstract
Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism. The optimal dose of low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy and the post-partum period is uncertain.
- Published
- 2022
- Full Text
- View/download PDF
32. Stroke genetics informs drug discovery and risk prediction across ancestries
- Author
-
Mishra, Aniket, Malik, Rainer, Hachiya, Tsuyoshi, Jürgenson, Tuuli, Namba, Shinichi, Posner, Daniel C., Kamanu, Frederick K., Koido, Masaru, Le Grand, Quentin, Shi, Mingyang, He, Yunye, Georgakis, Marios K., Caro, Ilana, Krebs, Kristi, Liaw, Yi-Ching, Vaura, Felix C., Lin, Kuang, Winsvold, Bendik Slagsvold, Srinivasasainagendra, Vinodh, Parodi, Livia, Bae, Hee-Joon, Chauhan, Ganesh, Chong, Michael R., Tomppo, Liisa, Akinyemi, Rufus, Roshchupkin, Gennady V., Habib, Naomi, Jee, Yon Ho, Thomassen, Jesper Qvist, Abedi, Vida, Cárcel-Márquez, Jara, Nygaard, Marianne, Leonard, Hampton L., Yang, Chaojie, Yonova-Doing, Ekaterina, Knol, Maria J., Lewis, Adam J., Judy, Renae L., Ago, Tetsuro, Amouyel, Philippe, Armstrong, Nicole D., Bakker, Mark K., Bartz, Traci M., Bennett, David A., Bis, Joshua C., Bordes, Constance, Børte, Sigrid, Cain, Anael, Ridker, Paul M., Cho, Kelly, Chen, Zhengming, Cruchaga, Carlos, Cole, John W., de Jager, Phil L., de Cid, Rafael, Endres, Matthias, Ferreira, Leslie E., Geerlings, Mirjam I., Gasca, Natalie C., Gudnason, Vilmundur, Hata, Jun, He, Jing, Heath, Alicia K., Ho, Yuk-Lam, Havulinna, Aki S., Hopewell, Jemma C., Hyacinth, Hyacinth I., Inouye, Michael, Jacob, Mina A., Jeon, Christina E., Jern, Christina, Kamouchi, Masahiro, Keene, Keith L., Kitazono, Takanari, Kittner, Steven J., Konuma, Takahiro, Kumar, Amit, Lacaze, Paul, Launer, Lenore J., Lee, Keon-Joo, Lepik, Kaido, Li, Jiang, Li, Liming, Manichaikul, Ani, Markus, Hugh S., Marston, Nicholas A., Meitinger, Thomas, Mitchell, Braxton D., Montellano, Felipe A., Morisaki, Takayuki, Mosley, Thomas H., Nalls, Mike A., Nordestgaard, Børge G., O’Donnell, Martin J., Okada, Yukinori, Onland-Moret, N. Charlotte, Ovbiagele, Bruce, Peters, Annette, Psaty, Bruce M., Rich, Stephen S., Rosand, Jonathan, Sabatine, Marc S., Sacco, Ralph L., Saleheen, Danish, Sandset, Else Charlotte, Salomaa, Veikko, Sargurupremraj, Muralidharan, Sasaki, Makoto, Satizabal, Claudia L., Schmidt, Carsten O., Shimizu, Atsushi, Smith, Nicholas L., Sloane, Kelly L., Sutoh, Yoichi, Sun, Yan V., Tanno, Kozo, Tiedt, Steffen, Tatlisumak, Turgut, Torres-Aguila, Nuria P., Tiwari, Hemant K., Trégouët, David-Alexandre, Trompet, Stella, Tuladhar, Anil Man, Tybjærg-Hansen, Anne, van Vugt, Marion, Vibo, Riina, Verma, Shefali S., Wiggins, Kerri L., Wennberg, Patrik, Woo, Daniel, Wilson, Peter W. F., Xu, Huichun, Yang, Qiong, Yoon, Kyungheon, Millwood, Iona Y., Gieger, Christian, Ninomiya, Toshiharu, Grabe, Hans J., Jukema, J. Wouter, Rissanen, Ina L., Strbian, Daniel, Kim, Young Jin, Chen, Pei-Hsin, Mayerhofer, Ernst, Howson, Joanna M. M., Irvin, Marguerite R., Adams, Hieab, Wassertheil-Smoller, Sylvia, Christensen, Kaare, Ikram, Mohammad A., Rundek, Tatjana, Worrall, Bradford B., Lathrop, G. Mark, Riaz, Moeen, Simonsick, Eleanor M., Kõrv, Janika, França, Paulo H. C., Zand, Ramin, Prasad, Kameshwar, Frikke-Schmidt, Ruth, de Leeuw, Frank-Erik, Liman, Thomas, Haeusler, Karl Georg, Ruigrok, Ynte M., Heuschmann, Peter Ulrich, Longstreth, W. T., Jung, Keum Ji, Bastarache, Lisa, Paré, Guillaume, Damrauer, Scott M., Chasman, Daniel I., Rotter, Jerome I., Anderson, Christopher D., Zwart, John-Anker, Niiranen, Teemu J., Fornage, Myriam, Liaw, Yung-Po, Seshadri, Sudha, Fernández-Cadenas, Israel, Walters, Robin G., Ruff, Christian T., Owolabi, Mayowa O., Huffman, Jennifer E., Milani, Lili, Kamatani, Yoichiro, Dichgans, Martin, and Debette, Stephanie
- Abstract
Previous genome-wide association studies (GWASs) of stroke — the second leading cause of death worldwide — were conducted predominantly in populations of European ancestry1,2. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P< 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis3, and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2Aand FURIN) and variants (such as at GRK5and NOS3). Using a three-pronged approach4, we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry5. Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries.
- Published
- 2022
- Full Text
- View/download PDF
33. The Role of Microelectrode Recording in Deep Brain Stimulation Surgery for Parkinson’s Disease: A Systematic Review and Meta-Analysis
- Author
-
Vinke, R. Saman, Geerlings, Martin, Selvaraj, Ashok K., Georgiev, Dejan, Bloem, Bastiaan R., Esselink, Rianne A.J., and Bartels, Ronald H.M.A.
- Abstract
STN-DBS is a cornerstone in the treatment of advanced Parkinson’s disease (PD). The traditional approach is to use an awake operative technique with microelectrode recording (MER). However, more centers start using an asleep MRI-guided technique without MER. We systematically reviewed the literature to compare STN-DBS surgery with and without MER for differences in clinical outcome. We systematically searched PubMed, Embase, MEDLINE, and Web of Science databases for randomized clinical trials and consecutive cohort studies published between 01-01-2000 and 26-08-2021, that included at least 10 PD patients who had received bilateral STN-DBS. 2,129 articles were identified. After abstract screening and full-text review, 26 studies were included in the final analysis, comprising a total of 34 study groups (29 MER and 5 non-MER). The standardized mean difference (SMD) in change in motor symptoms between baseline (OFF medication) and 6–24 months follow-up (OFF medication and ON stimulation) was 1.64 for the MER group and 1.87 for non-MER group (p = 0.59). SMD in change in levodopa equivalent daily dose (LEDD) was 1.14 for the MER group and 0.65 for non-MER group (p < 0.01). Insufficient data were available for comparative analysis of PDQ-39 and complications. The change in motor symptoms from baseline to follow-up did not differ between studies that used MER and those that did not. The postoperative reduction in LEDD from baseline to follow-up was greater in the MER-group. In the absence of high-quality studies comparing both methods, there is a clear need for a well-designed comparative trial.
- Published
- 2022
- Full Text
- View/download PDF
34. Dynamic metabolic interactions and trophic roles of human gut microbes identified using a minimal microbiome exhibiting ecological properties
- Author
-
Shetty, Sudarshan A, Kostopoulos, Ioannis, Geerlings, Sharon Y, Smidt, Hauke, de Vos, Willem M, and Belzer, Clara
- Abstract
Microbe–microbe interactions in the human gut are influenced by host-derived glycans and diet. The high complexity of the gut microbiome poses a major challenge for unraveling the metabolic interactions and trophic roles of key microbes. Synthetic minimal microbiomes provide a pragmatic approach to investigate their ecology including metabolic interactions. Here, we rationally designed a synthetic microbiome termed Mucin and Diet based Minimal Microbiome (MDb-MM) by taking into account known physiological features of 16 key bacteria. We combined 16S rRNA gene-based composition analysis, metabolite measurements and metatranscriptomics to investigate community dynamics, stability, inter-species metabolic interactions and their trophic roles. The 16 species co-existed in the in vitro gut ecosystems containing a mixture of complex substrates representing dietary fibers and mucin. The triplicate MDb-MM’s followed the Taylor’s power law and exhibited strikingly similar ecological and metabolic patterns. The MDb-MM exhibited resistance and resilience to temporal perturbations as evidenced by the abundance and metabolic end products. Microbe-specific temporal dynamics in transcriptional niche overlap and trophic interaction network explained the observed co-existence in a competitive minimal microbiome. Overall, the present study provides crucial insights into the co-existence, metabolic niches and trophic roles of key intestinal microbes in a highly dynamic and competitive in vitro ecosystem.
- Published
- 2022
- Full Text
- View/download PDF
35. Development and Validation of a Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) Assay for the Determination of Total and Unbound Ciprofloxacin Concentrations in Human Plasma
- Author
-
de Vroom, Suzanne L., Pistorius, Marcel C. M., Bijleveld, Yuma A., Geerlings, Suzanne E., Mathôt, Ron A. A., van Hest, Reinier M., and Jager, Nynke G. L.
- Published
- 2022
- Full Text
- View/download PDF
36. Association between plasma Alzheimer's disease markers and MRI markers of cerebral small vessel disease and neurodegeneration: the SMART‐MR Study.
- Author
-
Twait, Emma L., Gerritsen, Lotte, Moonen, Justine E., Verberk, Inge M.W., Teunissen, Charlotte E., Visser, Pieter Jelle, van der Flier, Wiesje M., and Geerlings, Mirjam I.
- Abstract
Background: Biomarkers for Alzheimer's disease (AD), including amyloid‐beta (Abeta) and phosphorylated‐tau have recently been accurately detected in blood. Non‐specific biomarkers such as neurofilament light (NFL) and glial fibrillary acidic protein (GFAP) have been added as complementary biomarkers to fully investigate AD etiology in vivo. This has increased the possibility to examine relationships with other pathways to AD, such as white matter hyperintensities (WMH) and brain atrophy on MRI. Our aim was to explore the relationship between plasma AD biomarkers and MRI markers of cerebral small vessel disease and neurodegeneration in mid‐ and late life. Method: Data from 594 individuals (mean (SD) age: 64 (8) years; 17% female) were included from the SMART‐MR Study, a prospective cohort study of non‐demented individuals with a history of vascular disease from the UMC Utrecht in the Netherlands. MRI markers of CSVD included WMH, presence of infarcts, total brain volume (TBV), and hippocampal volume (HV) assessed on 1.5T MRI. AD plasma markers (Abeta1‐40, Abeta1‐42, pTau‐181, NFL, and GFAP) were assessed using Single Molecular Array (Simoa; Quanterix) assays. Linear regressions were performed for each plasma marker, as well as Abeta1‐42/Abeta1‐40 ratio, with age, sex, education, and intracranial volume, with WMH volume, TBV, and HV. Additionally, logistic regressions were performed for the presence of infarcts, including lacunar infarcts and cortical infarcts, corrected for age, sex, and education. Plasma AD levels were converted to z‐scores. P < 0.01 was considered statistically significant. Result: Higher NFL and pTau‐181 were associated with larger WMH volume (B NFL=0.17, 95% CI=0.06;0.29, p=0.003; B pTau‐181=0.16, 95% CI=0.06;0.26, p=0.001). Higher Abeta1‐40 (B=‐0.11, 95% CI=‐0.17;‐0.05, p<0.001) levels were associated with lower HV. Higher NFL (B=‐5.63, 95% CI=‐8.95;‐2.31, p<0.001) and Abeta1‐42 (B=‐3.61, 95% CI=‐6.26;‐0.96, p=0.008) were associated with lower TBV. Regarding infarcts, higher NFL was associated with any infarct (OR=1.42, 95% CI=1.13;1.78, p=0.003). Higher GFAP was marginally associated only with cortical infarcts (OR=1.45, 95% CI=1.09;1.92, p=0.01). Conclusion: Within non‐demented adults with a history vascular disease, plasma AD markers differentially mapped to MRI markers. NFL and pTau‐181 were associated with markers reflecting vascular damage, whereas amyloid markers were associated with atrophy in the TBV and HV. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
37. Predictors of Incident Mild Cognitive Impairment and Its Course in a Diverse Community-Based Population.
- Author
-
Angevaare, Milou J., Vonk, Jet M.J., Bertola, Laiss, Zahodne, Laura, Watson, Caitlin Wei-Ming, Boehme, Amelia, Schupf, Nicole, Mayeux, Richard, Geerlings, Mirjam I., and Manly, Jennifer J.
- Published
- 2022
- Full Text
- View/download PDF
38. Long-term musculoskeletal function after Open PElvic ring fractures in Children (OPEC); a multicentre, retrospective case series with follow-up measurement
- Author
-
Mennen, A.H.M., Van Lieshout, E.M.M., Bisoen, P.A., Bloemers, F.W., Geerlings, A.E., Koole, D., Verhofstad, M.H.J., Visser, J.J., Van Embden, D., and Van Vledder, M.G.
- Abstract
The proportion of open pelvic fractures in the paediatric population is relatively high. While operative fixation is the primary approach for managing open pelvic fractures in adults, there is limited literature on treatment outcomes in Children, particularly regarding long-term musculoskeletal, neurological, and urogenital function.
- Published
- 2024
- Full Text
- View/download PDF
39. The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease
- Author
-
Vinke, R. Saman, Selvaraj, Ashok K., Geerlings, Martin, Georgiev, Dejan, Sadikov, Aleksander, Kubben, Pieter L., Doorduin, Jonne, Praamstra, Peter, Bloem, Bastiaan R., Bartels, Ronald H.M.A., and Esselink, Rianne A.J.
- Abstract
Bilateral deep brain stimulation of the subthalamic nucleus (STN-DBS) has become a cornerstone in the advanced treatment of Parkinson’s disease (PD). Despite its well-established clinical benefit, there is a significant variation in the way surgery is performed. Most centers operate with the patient awake to allow for microelectrode recording (MER) and intraoperative clinical testing. However, technical advances in MR imaging and MRI-guided surgery raise the question whether MER and intraoperative clinical testing still have added value in DBS-surgery. To evaluate the added value of MER and intraoperative clinical testing to determine final lead position in awake MRI-guided and stereotactic CT-verified STN-DBS surgery for PD. 29 consecutive patients were analyzed retrospectively. Patients underwent awake bilateral STN-DBS with MER and intraoperative clinical testing. The role of MER and clinical testing in determining final lead position was evaluated. Furthermore, interobserver variability in determining the MRI-defined STN along the planned trajectory was investigated. Clinical improvement was evaluated at 12 months follow-up and adverse events were recorded. 98% of final leads were placed in the central MER-track with an accuracy of 0.88±0.45 mm. Interobserver variability of the MRI-defined STN was 0.84±0.09. Compared to baseline, mean improvement in MDS-UPDRS-III, PDQ-39 and LEDD were 26.7±16.0 points (54%) (p < 0.001), 9.0±20.0 points (19%) (p = 0.025), and 794±434 mg/day (59%) (p < 0.001) respectively. There were 19 adverse events in 11 patients, one of which (lead malposition requiring immediate postoperative revision) was a serious adverse event. MER and intraoperative clinical testing had no additional value in determining final lead position. These results changed our daily clinical practice to an asleep MRI-guided and stereotactic CT-verified approach.
- Published
- 2022
- Full Text
- View/download PDF
40. Clinical Outcome After Endovascular Treatment in Patients With Active Cancer and Ischemic Stroke
- Author
-
Verschoof, Merelijne A., Groot, Adrien E., de Bruijn, Sebastiaan F.T.M., Roozenbeek, Bob, van der Worp, H. Bart, Dippel, Diederik W.J., Emmer, Bart J., Roosendaal, Stefan D., Majoie, Charles B.L.M., Roos, Yvo B.W.E.M., Coutinho, Jonathan M., Dippel, Diederik W.J., van der Lugt, Aad, Majoie, Charles B.L.M., Roos, Yvo B.W.E.M., van Oostenbrugge, Robert J., van Zwam, Wim H., Boiten, Jelis, Vos, Jan Albert, Jansen, Ivo G.H., Mulder, Maxim J.H.L., Goldhoorn, Robert-Jan B., Schonewille, Wouter J., Coutinho, Jonathan M., Wermer, Marieke J.H., van Walderveen, Marianne A.A., Staals, Julie, Hofmeijer, Jeannette, Martens, Jasper M., Lycklama à Nijeholt, Geert J., Roozenbeek, Bob, Emmer, Bart J., de Bruijn, Sebastiaan F., van Dijk, Lukas C., Bart van der Worp, H., Lo, Rob H., van Dijk, Ewoud J., Boogaarts, Hieronymus D., de Kort, Paul L.M., Peluso, Jo J.P., van den Berg, Jan S.P., van Hasselt, Boudewijn A.A.M., Aerden, Leo A.M., Dallinga, René J., Uyttenboogaart, Maarten, Eshghi, Omid, Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Keizer, Koos, Yo, Lonneke S.F., den Hertog, Heleen M., Sturm, Emiel J.C., Sprengers, Marieke E.S., Jenniskens, Sjoerd F.M., van den Berg, René, Yoo, Albert J., Beenen, Ludo F.M., Postma, Alida A., Roosendaal, Stefan D., van der Kallen, Bas F.W., van den Wijngaard, Ido R., van Es, Adriaan C.G.M., Bot, Joost, Doormaal, Pieter-Jan van, Flach, H. Zwenneke, Lingsma, Hester F., Ghannouti, Naziha el, Ghannouti, Naziha el, Puppels, Corina, Pellikaan, Wilma, Sprengers, Rita, Sprengers, Rita, de Meris, Joke, Vermeulen, Tamara, Geerlings, Annet, van Vemde, Gina, Simons, Tiny, van Rijswijk, Cathelijn, Messchendorp, Gert, Bongenaar, Hester, Bodde, Karin, Kleijn, Sandra, Lodico, Jasmijn, Droste, Hanneke, Wollaert, M., Jeurrissen, D., Bos, Erna, Drabbe, Yvonne, Zweedijk, Berber, Khalilzada, Mostafa, Venema, Esmee, Chalos, Vicky, Compagne, Kars C.J., Geuskens, Ralph R., van Straaten, Tim, Ergezen, Saliha, Harmsma, Roger R.M., Muijres, Daan, de Jong, Anouk, Hinsenveld, Wouter, Berkhemer, Olvert A., Boers, Anna M.M., Huguet, J., Groot, P.F.C., Mens, Marieke A., van Kranendonk, Katinka R., van Kranendonk, Katinka R., Kappelhof, Manon, Tolhuijsen, Manon L., and Alves, Heitor
- Published
- 2022
- Full Text
- View/download PDF
41. Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness
- Author
-
Hageman, Steven H J, Dorresteijn, Jannick A N, Bots, Michiel L, Asselbergs, Folkert W, Westerink, Jan, van der Meulen, Miriam P, Mosterd, Arend, Visseren, Frank L J, Asselbergs, F W, Nathoe, H M, de Borst, G J, Bots, M L, Geerlings, M I, Emmelot, M H, de Jong, P A, Leiner, T, Lely, A T, van der Kaaij, N P, Kappelle, L J, Ruigrok, Y M, Verhaar, M C, Visseren, F L J, and Westerink, J
- Published
- 2022
- Full Text
- View/download PDF
42. Designing Force Probes Based on Reversible 6π-Electrocyclizations in Polyenes Using Quantum Chemical Calculations.
- Author
-
Bettens, Tom, Eeckhoudt, Jochen, Hoffmann, Marvin, Alonso, Mercedes, Geerlings, Paul, Dreuw, Andreas, and De Proft, Frank
- Published
- 2021
- Full Text
- View/download PDF
43. Biomarkers of microvascular dysfunction and cerebral white matter connectivity: The Maastricht Study.
- Author
-
Beran, Magdalena, van Gennip, April C.E., Stehouwer, Coen D.A., Jansen, Jacobus F.A., Gupta, Monideepa D., Houben, Alfons J.H.M., Berendschot, Tos T.J.M., Webers, Carroll A.B., Wesselius, Anke, Schalkwijk, Casper, Backes, Walter H., de Jong, Joost J., van der Kallen, Carla J.H., van Greevenbroek, Marleen M.J., Köhler, Sebastian, Vonk, Jet M.J., Geerlings, Mirjam I., Schram, Miranda T., and van Sloten, Thomas T.
- Abstract
Background: Microvascular dysfunction may contribute to the development of various cerebral disorders, including cognitive dysfunction, dementia, and certain forms of depression. The suggested mechanism through which microvascular dysfunction contributes to these disorders is by disrupting white matter tracts and altering brain connectivity, but evidence is scarce. We investigated the association between multiple biomarkers of microvascular function and cerebral white matter connectivity. Method: We used cross‐sectional data from The Maastricht Study, a Dutch population‐based cohort (n = 4,326, mean±SD age 59.4±8.6 years, 49.7% women). Measures of microvascular function included urinary albumin excretion, central retinal arteriolar and venular calibers (CRAE and CRVE), a composite score of flicker light‐induced retinal arteriolar and venular dilation response, and a composite score of plasma biomarkers of endothelial dysfunction (soluble intercellular adhesion molecule‐1 (sICAM‐1), soluble vascular cell adhesion molecule‐1 (sVCAM‐1), soluble E‐selectin (sE‐selectin) and von Willebrand factor (vWF)). White matter connectivity was calculated from 3T diffusion MRI to quantify the number (average node degree) and organization (characteristic path length, global efficiency, clustering coefficient and local efficiency) of cerebral white matter connections. Result: A higher endothelial dysfunction composite score was associated with a longer characteristic path length (beta per SD: 0.066 (95% confidence interval: 0.017; 0.114)) after adjustment for sociodemographic, lifestyle and cardiovascular factors, but not with any of the other white matter connectivity measures. All other measures of microvascular dysfunction were not associated with any of the connectivity measures after adjustments. Conclusion: The present study suggests that microvascular dysfunction, as quantified by a set of various measures, is not consistently associated with cerebral white matter connectivity. Only a composite score of plasma biomarkers of endothelial dysfunction was associated with a longer characteristic path length, with a longer characteristic path length being indicative for a topographically less integrated and less efficient cerebral network. Future cross‐sectional and longitudinal studies are needed to further understand the role of microvascular dysfunction in the development of cerebral disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Predictors of Incident Mild Cognitive Impairment and Its Course in a Diverse Community-Based Population
- Author
-
Angevaare, Milou J., Vonk, Jet M.J., Bertola, Laiss, Zahodne, Laura, Watson, Caitlin Wei-Ming, Boehme, Amelia, Schupf, Nicole, Mayeux, Richard, Geerlings, Mirjam I., and Manly, Jennifer J.
- Published
- 2022
- Full Text
- View/download PDF
45. Dynamic metabolic interactions and trophic roles of human gut microbes identified using a minimal microbiome exhibiting ecological properties
- Author
-
Shetty, Sudarshan A., Kostopoulos, Ioannis, Geerlings, Sharon Y., Smidt, Hauke, de Vos, Willem M., and Belzer, Clara
- Abstract
Microbe–microbe interactions in the human gut are influenced by host-derived glycans and diet. The high complexity of the gut microbiome poses a major challenge for unraveling the metabolic interactions and trophic roles of key microbes. Synthetic minimal microbiomes provide a pragmatic approach to investigate their ecology including metabolic interactions. Here, we rationally designed a synthetic microbiome termed Mucin and Diet based Minimal Microbiome (MDb-MM) by taking into account known physiological features of 16 key bacteria. We combined 16S rRNA gene-based composition analysis, metabolite measurements and metatranscriptomics to investigate community dynamics, stability, inter-species metabolic interactions and their trophic roles. The 16 species co-existed in the in vitro gut ecosystems containing a mixture of complex substrates representing dietary fibers and mucin. The triplicate MDb-MM’s followed the Taylor’s power law and exhibited strikingly similar ecological and metabolic patterns. The MDb-MM exhibited resistance and resilience to temporal perturbations as evidenced by the abundance and metabolic end products. Microbe-specific temporal dynamics in transcriptional niche overlap and trophic interaction network explained the observed co-existence in a competitive minimal microbiome. Overall, the present study provides crucial insights into the co-existence, metabolic niches and trophic roles of key intestinal microbes in a highly dynamic and competitive in vitro ecosystem.
- Published
- 2022
- Full Text
- View/download PDF
46. Registration of catheter-related complications in adverse events reporting systems: a major underestimation of the real complication practice
- Author
-
Laan, Bart J, Godfried, Mieke H, and Geerlings, Suzanne E
- Abstract
Reporting and learning from preventable adverse events is crucial to improve patient safety. Although physicians should file and analyse adverse events by law in The Netherlands, it is unknown if these reporting systems are sufficiently used in clinical practice. This study is a substudy of the multicenter RICAT trial, a successful quality improvement project to reduce inappropriate use of intravenous and urinary catheters in medical wards in seven hospitals, in which we screened 5696 patients and documented 803 catheter-related complications. We also checked the adverse events reporting systems of these patients and found that only 13 (1.6%) of 803 catheter-related complications were registered. Of the infectious complications only five (10.9%) of 46 catheter-associated bloodstream infections and urinary tract infections were registered. We conclude that the reported complications were a major underestimation of the real complication practice in medical wards in The Netherlands.The RICAT trial is registered at Netherlands Trial Register, trial NL5438.
- Published
- 2022
- Full Text
- View/download PDF
47. Who is providing HIV diagnostic testing? Comparing HIV testing by general practitioners and sexual health centres in five regions in the Netherlands, 2011−2018
- Author
-
Bogers, Saskia J, Twisk, Denise E, Beckers, Loes M, Go¨tz, Hannelore M, Meima, Bram, Kroone, Michelle, Hoornenborg, Elske, Ott, Alewijn, Luning-Koster, Marleen N, Dukers-Muijrers, Nicole H T M, Hoebe, Christian J P A, Kampman, Carolina J G, Bosma, Froukje, Schim van der Loeff, Maarten, Geerlings, Suzanne, and van Bergen, Jan
- Abstract
ObjectivesGeneral practitioners (GPs) and sexual health centres (SHCs) are the main providers of HIV testing and diagnose two-thirds of HIV infections in the Netherlands. We compared regional HIV testing and positivity by GPs versus SHCs to gain insight into strategies to improve HIV testing, to enable timely detection of HIV infections.MethodsLaboratory data (2011–2018) on HIV testing by GPs and SHCs in five Dutch regions with varying levels of urbanisation were evaluated. Regional HIV testing rates per 10 000 residents ≥15 years (mean over period and annual) were compared between providers using negative binomial generalised additive models and additionally stratified by sex and age (15–29 years, 30–44 years, 45–59 years, ≥60 years). χ2tests were used to compare positivity percentage between the two groups of providers.ResultsIn the study period, 505 167 HIV tests (GP 36%, SHC 64%) were performed. The highest HIV testing rates were observed in highly urbanised regions, with large regional variations. The HIV testing rates ranged from 28 to 178 per 10 000 residents by GPs and from 30 to 378 per 10 000 by SHCs. Testing rates by GPs were lower than by SHCs in three regions and comparable in two. In all regions, men were tested less by GPs than by SHCs; for women, this varied by region. Among those aged 15–29 years old, GPs’ testing rates were lower than SHCs’, while this was reversed in older age categories in four out of five regions. The overall mean HIV positivity was 0.4%. In contrast to other regions, positivity in Amsterdam was significantly higher among individuals tested by GPs than by SHCs.ConclusionsThis retrospective observational study shows that besides SHCs, who perform opt-out testing for key groups, GPs play a prominent role in HIV testing, especially in non-key populations, such as women and older individuals. Large regional variation exists, requiring region-specific interventions to improve GPs’ HIV testing practices.
- Published
- 2022
- Full Text
- View/download PDF
48. Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
- Author
-
Bistervels, Ingrid M., Geerlings, Abby E., Bonta, Peter I., Ganzevoort, Wessel, Zijlstra, IJsbrand A.J., and Middeldorp, Saskia
- Abstract
Patients with an inferior vena cava (IVC) filter that remains in situ encounter a lifelong increased risk of deep vein thrombosis and IVC filter complications including fracture, perforation, and IVC filter thrombotic occlusion. Data on the safety of becoming pregnant with an in situ IVC filter are scarce. The objective was to evaluate the risk of complications of in situ IVC filters during pregnancy. We performed a retrospective cohort study of pregnant patients with an in situ IVC filter from a tertiary center between 2000 and 2020. We collected data on complications of IVC filters and pregnancy outcomes. Additionally, we performed a systematic literature search in MEDLINE, Embase, and gray literature. We identified 7 pregnancies in 4 patients with in situ IVC filters with a mean time since IVC filter insertion of 3 years (range, 1-8). No complications of IVC filter occurred during pregnancy. Review of literature yielded five studies including 13 pregnancies in 9 patients. In 1 pregnancy a pre-existent, until then asymptomatic, chronic perforation of the vena cava wall by the IVC filter caused major bleeding and uterine trauma with fetal loss. Overall, the complication rate was 5%. It seems safe to become pregnant with an indwelling IVC filter that is intact and does not show signs of perforation, but because of the low number of cases, no firm conclusions about safety of in situ IVC filters during pregnancy can be drawn. We suggest imaging before pregnancy to reveal asymptomatic IVC filter complications.
- Published
- 2021
- Full Text
- View/download PDF
49. Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
- Author
-
Bistervels, Ingrid M., Geerlings, Abby E., Bonta, Peter I., Ganzevoort, Wessel, Zijlstra, IJsbrand A.J., and Middeldorp, Saskia
- Abstract
Patients with an inferior vena cava (IVC) filter that remains in situ encounter a lifelong increased risk of deep vein thrombosis and IVC filter complications including fracture, perforation, and IVC filter thrombotic occlusion. Data on the safety of becoming pregnant with an in situ IVC filter are scarce. The objective was to evaluate the risk of complications of in situ IVC filters during pregnancy. We performed a retrospective cohort study of pregnant patients with an in situ IVC filter from a tertiary center between 2000 and 2020. We collected data on complications of IVC filters and pregnancy outcomes. Additionally, we performed a systematic literature search in MEDLINE, Embase, and gray literature. We identified 7 pregnancies in 4 patients with in situ IVC filters with a mean time since IVC filter insertion of 3 years (range, 1-8). No complications of IVC filter occurred during pregnancy. Review of literature yielded five studies including 13 pregnancies in 9 patients. In 1 pregnancy a pre-existent, until then asymptomatic, chronic perforation of the vena cava wall by the IVC filter caused major bleeding and uterine trauma with fetal loss. Overall, the complication rate was 5%. It seems safe to become pregnant with an indwelling IVC filter that is intact and does not show signs of perforation, but because of the low number of cases, no firm conclusions about safety of in situ IVC filters during pregnancy can be drawn. We suggest imaging before pregnancy to reveal asymptomatic IVC filter complications.
- Published
- 2021
- Full Text
- View/download PDF
50. Association of Ischemic Imaging Phenotype With Progression of Brain Atrophy and Cerebrovascular Lesions on MRI
- Author
-
Rissanen, Ina, Lucci, Carlo, Ghaznawi, Rashid, Hendrikse, Jeroen, Kappelle, L. Jaap, Geerlings, Mirjam I., Visseren, Frank L.J., Asselbergs, Folkert W., Nathoe, Hendrik M., Bots, Michiel L., Emmelot- Vonk, Marielle H., Jan de Borst, Gert, Leiner, Tim, de Jong, Pim A., Lely, A. Titia, van der Kaaij, Niels P., Ruigrok, Ynte M., Verhaar, Marianne C., and Westerink, Jan
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.